| # | Title | Journal | Year | Citations |
|---|
| 1 | No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection | Médecine Et Maladies Infectieuses | 2020 | 620 |
| 2 | Current Zika virus epidemiology and recent epidemics | Médecine Et Maladies Infectieuses | 2014 | 470 |
| 3 | C-reactive protein levels in the early stage of COVID-19 | Médecine Et Maladies Infectieuses | 2020 | 470 |
| 4 | Features of anosmia in COVID-19 | Médecine Et Maladies Infectieuses | 2020 | 320 |
| 5 | Probiotics, gut microbiota and health | Médecine Et Maladies Infectieuses | 2014 | 290 |
| 6 | Interleukin-6 as a potential biomarker of COVID-19 progression | Médecine Et Maladies Infectieuses | 2020 | 254 |
| 7 | Targeting mechanisms of Pseudomonas aeruginosa pathogenesis | Médecine Et Maladies Infectieuses | 2006 | 244 |
| 8 | Diagnosis and epidemiology of leptospirosis | Médecine Et Maladies Infectieuses | 2013 | 236 |
| 9 | Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients | Médecine Et Maladies Infectieuses | 2020 | 214 |
| 10 | Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge | Médecine Et Maladies Infectieuses | 2014 | 196 |
| 11 | Phage therapy experience at the Eliava Institute | Médecine Et Maladies Infectieuses | 2008 | 183 |
| 12 | French guidelines for the management of chikungunya (acute and persistent presentations). November 2014 | Médecine Et Maladies Infectieuses | 2015 | 173 |
| 13 | Propionibacterium acnes, an emerging pathogen: From acne to implant-infections, from phylotype to resistance | Médecine Et Maladies Infectieuses | 2014 | 163 |
| 14 | The impact of the web and social networks on vaccination. New challenges and opportunities offered to fight against vaccine hesitancy | Médecine Et Maladies Infectieuses | 2016 | 121 |
| 15 | Ticks and tick-borne diseases | Médecine Et Maladies Infectieuses | 2019 | 120 |
| 16 | Epidemiology of infectious encephalitis causes in 2016 | Médecine Et Maladies Infectieuses | 2017 | 117 |
| 17 | Digestive tract mycobiota: A source of infection | Médecine Et Maladies Infectieuses | 2015 | 114 |
| 18 | Practice guidelines for the management of adult community-acquired urinary tract infections | Médecine Et Maladies Infectieuses | 2018 | 112 |
| 19 | Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis) | Médecine Et Maladies Infectieuses | 2010 | 108 |
| 20 | Update on blood culture-negative endocarditis | Médecine Et Maladies Infectieuses | 2015 | 106 |
| 21 | Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients | Médecine Et Maladies Infectieuses | 2014 | 104 |
| 22 | Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients | Médecine Et Maladies Infectieuses | 2002 | 99 |
| 23 | Q fever in the Netherlands – 2007–2010: What we learned from the largest outbreak ever | Médecine Et Maladies Infectieuses | 2014 | 93 |
| 24 | Update on the epidemiology, diagnosis, and treatment of leprosy | Médecine Et Maladies Infectieuses | 2015 | 91 |
| 25 | Update on counterfeit antibiotics worldwide; Public health risks | Médecine Et Maladies Infectieuses | 2012 | 88 |
| 26 | Guidelines on the management of infectious encephalitis in adults | Médecine Et Maladies Infectieuses | 2017 | 82 |
| 27 | Antibacterial and antifungal activity of lawsone and novel naphthoquinone derivatives | Médecine Et Maladies Infectieuses | 2012 | 81 |
| 28 | Ebola outbreak in Conakry, Guinea: Epidemiological, clinical, and outcome features | Médecine Et Maladies Infectieuses | 2014 | 79 |
| 29 | Diagnosis and management of prosthetic vascular graft infections | Médecine Et Maladies Infectieuses | 2012 | 78 |
| 30 | Case fatality rates of Ebola virus diseases: A meta-analysis of World Health Organization data | Médecine Et Maladies Infectieuses | 2014 | 76 |
| 31 | Phototoxicity and photocarcinogenesis associated with voriconazole | Médecine Et Maladies Infectieuses | 2011 | 75 |
| 32 | Azole resistant Aspergillus fumigatus: An emerging problem | Médecine Et Maladies Infectieuses | 2013 | 74 |
| 33 | Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection | Médecine Et Maladies Infectieuses | 2018 | 72 |
| 34 | Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic | Médecine Et Maladies Infectieuses | 2018 | 71 |
| 35 | Review of European and American guidelines for the diagnosis of Lyme borreliosis | Médecine Et Maladies Infectieuses | 2019 | 68 |
| 36 | Understanding the virulence of Streptococcus suis : A veterinary, medical, and economic challenge | Médecine Et Maladies Infectieuses | 2018 | 67 |
| 37 | Focus on Middle East respiratory syndrome coronavirus (MERS-CoV) | Médecine Et Maladies Infectieuses | 2020 | 65 |
| 38 | Influence of information sources on vaccine hesitancy and practices | Médecine Et Maladies Infectieuses | 2020 | 65 |
| 39 | Regulation of oxidative stress by Nrf2 in the pathophysiology of infectious diseases | Médecine Et Maladies Infectieuses | 2013 | 63 |
| 40 | Crimean-Congo hemorrhagic fever: An update | Médecine Et Maladies Infectieuses | 2019 | 63 |
| 41 | Epidemiology and prevention of surgical site infections after cardiac surgery | Médecine Et Maladies Infectieuses | 2013 | 62 |
| 42 | Mycoplasma genitalium, an emerging sexually transmitted pathogen | Médecine Et Maladies Infectieuses | 2012 | 60 |
| 43 | Epidemiology of Enterobacteriaceae producing CTX-M type extended spectrum β-lactamase (ESBL) | Médecine Et Maladies Infectieuses | 2014 | 58 |
| 44 | Update on infections with human herpesviruses 6A, 6B, and 7 | Médecine Et Maladies Infectieuses | 2017 | 58 |
| 45 | Clinical and microbiological features of Clostridium difficile infections in France: The ICD-RAISIN 2009 national survey | Médecine Et Maladies Infectieuses | 2013 | 57 |
| 46 | Proposal for shorter antibiotic therapies | Médecine Et Maladies Infectieuses | 2017 | 57 |
| 47 | Candida albicans and Pseudomonas aeruginosa interactions: More than an opportunistic criminal association? | Médecine Et Maladies Infectieuses | 2013 | 56 |
| 48 | Microparticles and infectious diseases | Médecine Et Maladies Infectieuses | 2012 | 55 |
| 49 | Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics? | Médecine Et Maladies Infectieuses | 2017 | 55 |
| 50 | Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis | Médecine Et Maladies Infectieuses | 2019 | 55 |
